An uncontrolled feasibility study on using mouth piece ventilation in palliation of dyspnea in subjects with acute exacerbation of COPD without acute hypercapnic respiratory failure. Subjects are recruited from the local respiratory ward. The main outcomes are the compliance of the subjects with the treatment and alleviation of dyspnea during the treatment period.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Mouth piece Ventilation (MPV) using Trilogy 100 ® (Philips Respironics).
Dpt of Respiratory Medicine, Tampere University Hospital
Tampere, Finland
Change in dyspnea after initial period of using MPV
Change in dyspnea after initial period of using MPV
Time frame: 5-60 min
Change in dyspnea after 24 hours of using MPV
Change in dyspnea after 24 hours of using MPV
Time frame: 24 hours
Proportion of subjects having side-effects or not being compliant with MPV
Proportion of subjects having side-effects or not being compliant with MPV
Time frame: 24 hours
Proportion of subjects gaining from MPV
Proportion of subjects gaining from MPV
Time frame: 24 hours
Proportion of subjects willing to continue on MPV after the intervention
Proportion of subjects willing to continue on MPV after the intervention
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.